Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for MPX International's Days Sales Outstanding or its related term are showing as below:
MPXOF's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 72 * Ranked among companies with meaningful Days Sales Outstanding only.
MPX International's Days Sales Outstanding
increased
from Mar. 2021 (28.27) to Mar. 2022 (30.90).
MPX International (OTCPK:MPXOF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
MPX International Days Sales Outstanding Related Terms
MPX International Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for MPX International's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MPXOF vs ZTS, CTLT, VTRS: Days Sales Outstanding Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MPX International Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MPX International's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where MPX International's Days Sales Outstanding falls into.
MPX International Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MPX International (MPXOF) has a Days Sales Outstanding of 30.90 as of Mar. 2022. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on MPX International and its competitors.
Is MPX International's Days Sales Outstanding too high?
MPX International's current Days Sales Outstanding is 30.90. The Drug Manufacturers industry median Days Sales Outstanding is 72.00. MPX International's value of 30.90 is 57.1% below this industry median.
How does MPX International's Days Sales Outstanding compare to ZTS and CTLT?
MPX International's Days Sales Outstanding of 30.90 can be compared against companies in the Drug Manufacturers industry. The industry median Days Sales Outstanding is 72.00. MPX International's value of 30.90 is 57.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 72.00, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MPX International's current Days Sales Outstanding of 30.90 is 57.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on MPX International and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 72.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPX International's current Days Sales Outstanding is 30.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current Days Sales Outstanding of 30.90. The current Days Sales Outstanding is 30.90 and 57.1% below the Drug Manufacturers industry median of 72.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For MPX International (MPXOF), the current Days Sales Outstanding is 30.90 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MPXOF has been successfully added to your 
